A BETTER CHOICE FOR DRUG DEVELOPMENT
A BETTER CHOICE FOR DRUG DEVELOPMENT
WHY INTACT 3D TUMOROIDS?
The tumor immune microenvironment (TME) is an important part of tumorigenesis. It is essential to maintain the extracellular matrix and the structural relationship of tumor and immune cells for reliable results.
Learn more about the TME and how Nilogen’s fresh patient 3D tumoroids keep this important structure intact.
ASSAYS
Using our fresh patient 3D tumoroids, Nilogen has validated and optimized assays for several applications for drug discovery and development including high-content imaging, cytokine analysis, flow cytometry, multiplex IHC, mutational analysis and gene expression analysis.
With a wide range of capabilities we can correlate results providing a comprehensive approach to drug development.
ASSAYS
Using our fresh patient 3D tumoroids, Nilogen has validated and optimized assays for several applications for drug discovery and development including high-content imaging, cytokine analysis, flow cytometry, multiplex IHC, mutational analysis and gene expression analysis.
With a wide range of capabilities we can correlate results providing a comprehensive approach to drug development.
WORKFLOW
Learn more about Nilogen’s fresh patient 3D tumoroid solutions and how we provide a better model system for every step of drug development.
WORKFLOW
Learn more about Nilogen’s fresh patient 3D tumoroid solutions and how we provide a better model system for every step of drug development.
